🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis b (recombinant) and haemophilus influenzae type b conjugate vaccine, adjuvanted

    HEXAVAC

    EMA: withdrawn

    J07CA

  2. diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed)

    HEXYON

    EMA: approved

    J07CA09

  3. diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)

    VAXELIS

    EMA: approved

    J07CA09

  4. diphtheria, tetanus, pertussis (whole cell), hepatitis b (rdna) and haemophilus influenzae type b conjugate vaccine (absorbed)

    QUINTANRIX

    EMA: withdrawn

    J07CA10

  5. diphtheria-tetanus-pertussis

    NMPA: clinical trials

  6. diphtheria-tetanus-pertussis-haemophilus

    NMPA: clinical trials

  7. dipivefrin hydrochloride

    PROPINE

    OPHTHALMIC FDA: approved

  8. diquafosol sodium

    DIQUAS

    PMDA: approved

  9. diroximel fumarate

    VUMERITY Biogen

    ORAL FDA: approved · EMA: approved · TGA: approved

    L04AX07

  10. disopyramide phosphate

    DISOPYRAMIDE PHOSPHATE Teva Pharma GmbH

    ORAL FDA: approved

  11. divalproex sodium

    DIVALPROEX SODIUM Amneal Pharma Europe Ltd

    ORAL FDA: approved

  12. dobutamine hydrochloride

    DOBUTAMINE HYDROCHLORIDE Teva Pharma GmbH

    INJECTION FDA: approved

  13. docusate + sennoside b

    CO-SENNA Lacuna Pharma Pty Ltd

    TGA: approved

  14. dolasetron mesylate

    ANZEMET

    INJECTION FDA: approved

  15. dolutegravir + abacavir + lamivudine

    TRIUMEQ ViiV Healthcare Pty Ltd

    TGA: approved

  16. dolutegravir + lamivudine

    DOVATO ViiV Healthcare Pty Ltd

    TGA: approved

  17. dolutegravir + rilpivirine

    JULUCA ViiV Healthcare Pty Ltd

    TGA: approved

  18. dolutegravir and lamivudine

    DOLUTEGRAVIR AND LAMIVUDINE

    FDA: approved

  19. dolutegravir lamivudine tenofovir alafenamide

    DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE

    FDA: approved

  20. dolutegravir sodium

    TIVICAY

    ORAL FDA: approved · PMDA: approved

  21. dolutegravir, emtricitabine and tenofovir alafenamide

    DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL FDA: approved

  22. donanemab-azbt

    KISUNLA

    INJECTION FDA: approved

  23. donepezil hydrochloride

    ADLARITY Amneal Pharma Europe Ltd

    TRANSDERMAL FDA: approved · NMPA: clinical trials

  24. donidalorsen sodium

    DAWNZERA (AUTOINJECTOR) IONIS PHARMACEUTICALS INC

    SUBCUTANEOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources